Outset Medical, Inc. Payments for Restructuring
Outset Medical, Inc. (OM) reported Payments for Restructuring of $1.53 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-02-13
- Outset Medical, Inc. payments for restructuring for the quarter ending 2025-12-31 was $0.00.
- Outset Medical, Inc. payments for restructuring for the quarter ending 2025-09-30 was $25.00K, a 98.77% decline year-over-year.
- Outset Medical, Inc. payments for restructuring for the quarter ending 2025-06-30 was $65.00K, a 96.92% decline year-over-year.
- Outset Medical, Inc. payments for restructuring for the quarter ending 2025-03-31 was $1.45M, a 85.02% increase year-over-year.
- Outset Medical, Inc. payments for restructuring for fiscal 2025 was $1.53M, a 68.72% decline from fiscal 2024.
- Outset Medical, Inc. payments for restructuring for fiscal 2024 was $4.91M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $25.00K derived: sum of 2 quarters · filed 2026-02-13 | $90.00K derived: sum of 3 quarters · filed 2026-02-13 | $1.53M 10-K · filed 2026-02-13 |
| 2025-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $90.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.53M 10-Q · filed 2025-11-10 | $1.52M derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.51M 10-Q · filed 2025-08-07 | $1.50M derived: sum of 3 quarters · filed 2025-08-07 | $3.53M derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | $1.45M 10-Q · filed 2025-05-08 | $1.43M derived: sum of 2 quarters · filed 2025-05-08 | $3.46M derived: sum of 3 quarters · filed 2025-05-08 | $5.57M derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $2.02M derived: sum of 2 quarters · filed 2025-02-28 | $4.13M derived: sum of 3 quarters · filed 2025-02-28 | $4.91M 10-K · filed 2025-02-28 |
| 2024-09-30 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $4.14M derived: sum of 2 quarters · filed 2024-11-07 | $4.92M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.89M 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $781.00K 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |